| |
Latest 10 SEC filings (by transaction date) for INZY within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 3/24 | Apr 2/24 | Treco Douglas A | Direct Ownership | Common Stock | S - Open market or private sale | -7,523 | $6.94 |
Apr 3/24 | Apr 1/24 | Treco Douglas A | Direct Ownership | Restricted Stock Units | M - Exercise or conversion exempt under rule 16b-3 | -25,000 | |
Apr 3/24 | Apr 1/24 | Treco Douglas A | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 25,000 | |
Apr 3/24 | Mar 28/24 | Winton Matthew | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 3,188 | $3.33 |
Mar 15/24 | Mar 13/24 | Winton Matthew | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 175,000 | |
Mar 15/24 | Mar 13/24 | Treco Douglas A | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 300,000 | |
Mar 15/24 | Mar 13/24 | Subramanian Sanjay | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 165,000 | |
Aug 3/23 | Aug 1/23 | Pivotal bioVenture Partners Fund I, L.P. | Indirect Ownership | Common Stock | P - Open market or private purchase | 714,285 | $4.80 |
Aug 3/23 | Aug 1/23 | Pivotal bioVenture Partners Fund I, L.P. | Indirect Ownership | Common Stock | P - Open market or private purchase | 119,048 | $4.80 |
Aug 3/23 | Aug 1/23 | Hopfner Robert Lorne | Indirect Ownership | Common Stock | P - Open market or private purchase | 714,285 | $4.80 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for INZY within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 3/24 | Apr 1/24 | Treco Douglas A | Direct Ownership | Restricted Stock Units | M - Exercise or conversion exempt under rule 16b-3 | -25,000 | |
Apr 3/24 | Apr 2/24 | Treco Douglas A | Direct Ownership | Common Stock | S - Open market or private sale | -7,523 | $6.94 |
Apr 3/24 | Apr 1/24 | Treco Douglas A | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 25,000 | |
Apr 3/24 | Mar 28/24 | Winton Matthew | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 3,188 | $3.33 |
Mar 15/24 | Mar 13/24 | Winton Matthew | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 175,000 | |
Mar 15/24 | Mar 13/24 | Treco Douglas A | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 300,000 | |
Mar 15/24 | Mar 13/24 | Subramanian Sanjay | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 165,000 | |
Aug 3/23 | Aug 1/23 | Pivotal bioVenture Partners Fund I, L.P. | Indirect Ownership | Common Stock | P - Open market or private purchase | 714,285 | $4.80 |
Aug 3/23 | Aug 1/23 | Pivotal bioVenture Partners Fund I, L.P. | Indirect Ownership | Common Stock | P - Open market or private purchase | 119,048 | $4.80 |
Aug 3/23 | Aug 1/23 | Hopfner Robert Lorne | Indirect Ownership | Common Stock | P - Open market or private purchase | 714,285 | $4.80 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Medpace Holdings (OQ:MEDP) |
United Therapeutics (OQ:UTHR) |
Disc Medicine (OQ:IRON) |